A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal Medicine: comparing the real-world registry data vs. randomized controlled trial.
Xinxing LaiZhenghao FangZhenyu DongShengxian WuXiao-Hua ZhouYing GaoPublished in: Clinical and experimental hypertension (New York, N.Y. : 1993) (2023)
The current comparison demonstrated that SXC monotherapy is at least as effective in real-world settings as within the randomized controlled trial for BP lowering in patients with grade 1 hypertension.